VTRS News and Press, Viatris Inc. From 09/30/23

2023-09-30 07:58:00 ET If you're investing $25,000 in your stock portfolio, then getting that investment to be worth $1 million over time is no simple task. Odds are, you'll have to wait decades for that investment to grow 40 times its original value, while also likely outperforming the mar...

2023-09-29 15:00:25 ET Summary Viatris Inc.'s Q2 2023 earnings presentation notes that generic forms of NVO's Ozempic and Wegovy are under regulatory review. Despite newer therapies, older drugs like Trulicity continue to generate significant revenues, so a generic semaglutide cou...

2023-09-27 09:22:17 ET More on Ocuphire Pharma, Viatris, etc. Why 5%-Yielding Viatris Hasn't Doubled Yet Viatris Emerges As Challenger In Lucrative Anti-Obesity Drugs Market Viatris: Turning Point For Cheap Pharma Stock Viatris in talks to sell European OTC a...

Viatris and Ocuphire Pharma Announce FDA Approval of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% Eye Drops for the Treatment of Pharmacologically-Induced Mydriasis Produced by Adrenergic Agonists (e.g., Phenylephrine) or Parasympatholytic (e.g., Tropicamide) Agents PR Newsw...

2023-09-22 05:00:26 ET Worried that the Federal Reserve is driving our economy off a cliff? I’ve got two words for you: Drugs ‘n diapers . Actually, I forgot one. Dividends . These companies are about as recession-resistant as they come. Let’...

2023-09-14 09:18:00 ET Inflation is giving investors more of an incentive to find ways to increase their income. If you have a decent nest egg saved up, you can use it to invest in dividend stocks to improve your financial position. It could be a better alternative than dipping into your sa...

2023-09-14 06:07:30 ET Summary Viatris is a healthcare corporation formed through a merger, with a diversified global portfolio and a focus on ophthalmology, gastrointestinal, and dermatology therapeutic areas. Despite its elevated debt load, Viatris has demonstrated strong financ...

Viatris Named to TIME's World's Best Companies 2023 List PR Newswire PITTSBURGH , Sept. 12, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has been named to TIME's World's Best Companies 2023 list ...

2023-09-09 07:20:00 ET On average, healthcare stocks haven't kept up with the gains made by the rest of the market this year. While the S&P 500 index is up by more than 17% year to date, that sector's stocks are down by nearly 3%. That trend, though, created some great opportunities...

2023-09-06 13:16:14 ET More on Viatris Seeking Alpha’s Quant Rating on Viatris Historical earnings data for Viatris Dividend scorecard for Viatris Financial information for Viatris Viatris Emerges As Challenger In Lucrative Anti-Obesity Drugs M...